EP3789402
COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES AND PD-1 AXIS BINDING ANTAGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.11.2015EP published:
13.7.2022EP application number:
20181448.0
EPO information:
European Patent Register
Max expiry date:
15.11.2035
Title in English:
COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES AND PD-1 AXIS BINDING ANTAGONISTSLanguage of the patent:
English
Timeline
Today
16.11.2015EP application
13.7.2022EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
KLEIN, ChristianAddress:
8952 Schlieren, CH
Name:
KARANIKAS, VaiosAddress:
8952 Schlieren, CH
Name:
UMAÑA, PabloAddress:
8952 Schlieren, CH
Name:
Zippelius, AlfredAddress:
4031 Basel, CH
Name:
Thommen, DanielaAddress:
4031 Basel, CH
Name:
Schreiner, JensAddress:
4031 Basel, CH
Priority
Number:
14194136Date:
20.11.2014Country:
EP
Number:
15152141Date:
22.1.2015Country:
EP
Number:
15167173Date:
11.5.2015Country:
EP
Classification
Categories:
C07K 16/28, A61K 39/00, A61K 47/68, A61P 1/04, A61P 11/00, A61P 13/12, A61P 15/00, A61P 35/00, A61P 43/00